A new approach in the treatment of peripheral arterial occlusions: defibrination with arvin.
D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D001809:Blood Viscosity / Q000187:drug effects*; D004341:Drug Evaluation; D005340:Fibrinogen / Q000032:analysis; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D007275:Injections, Intravenous; D007866:Leg / Q000098:blood supply*; D011517:Prothrombin Time; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use; D014688:Venoms
D005343:Fibrinolytic Agents; D014688:Venoms; D005340:Fibrinogen; D013299:Streptodornase and Streptokinase